China Universal Asset Management Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,817 shares of RARE stock, worth $636,001. This represents 0.1% of its overall portfolio holdings.
Number of Shares
15,817
Previous 15,817
-0.0%
Holding current value
$636,001
Previous $738,000
-0.0%
% of portfolio
0.1%
Previous 0.09%
Shares
12 transactions
Others Institutions Holding RARE
# of Institutions
286Shares Held
78.6MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$350 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.09MShares$285 Million5.31% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$211 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$165 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$155 Million0.53% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.82B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...